March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Access To Eye Care By Patients With Diabetes: A Retrospective Analysis
Author Affiliations & Notes
  • Ann P. Murchison
    Research, Wills Eye Institute, Philadelphia, Pennsylvania
  • Lisa A. Hark
    Research, Wills Eye Institute, Philadelphia, Pennsylvania
  • Julia A. Haller
    Research, Wills Eye Institute, Philadelphia, Pennsylvania
  • Joseph A. Malunda
    Research, Wills Eye Institute, Philadelphia, Pennsylvania
  • Benjamin Leiby
    Biostatistics, Jefferson Medical College, Philadelphia, Pennsylvania
  • Yang Dai
    Biostatistics, Jefferson Medical College, Philadelphia, Pennsylvania
  • Laura Pizzi
    Pharmacy, Jefferson School of Pharmacy, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  Ann P. Murchison, None; Lisa A. Hark, None; Julia A. Haller, None; Joseph A. Malunda, None; Benjamin Leiby, None; Yang Dai, None; Laura Pizzi, None
  • Footnotes
    Support  Centers for Disease Control and Prevention
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5744. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ann P. Murchison, Lisa A. Hark, Julia A. Haller, Joseph A. Malunda, Benjamin Leiby, Yang Dai, Laura Pizzi; Access To Eye Care By Patients With Diabetes: A Retrospective Analysis. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5744.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To conduct a 4-year retrospective analysis to evaluate factors that impact access to eye care for patients with diabetes.

 
Methods:
 

Electronic billing data was integrated with chart review data for patients with diabetes aged 40 years and older who were seen in the Wills Eye clinics between 1/1/2007-12/31/2010. Electronic data included evaluation date, diagnosis code(s), severity of diabetic retinopathy, demographic information, health insurance type(s), and referring physician. Chart review data included race/ethnicity, ocular co-morbidities, medications, duration of diabetes, presence of HgbA1C, date of dilated fundus exam (DFE), result of DFE, and ophthalmologist recommended follow-up. Multivariate analysis was used to examine predictors of DFE follow-up adherence

 
Results:
 

The mean age was 59 years (range 40-92 years) with 56% of the patients being female. The majority of the patients (86%) were from Pennsylvania, followed by New Jersey and Delaware (13%), and other states (1%). Most of the patients were African American (56%), unknown/unreported made up 24%, Caucasian 12%, Hispanic/Latino 5%, and Asian 3%. Annual follow-up was recommended for 74% of patients, within 6 months for 5%, and within 3 months for 21%. Most of the patients have only mild diabetic retinopathy. Adherence to follow-up was 48% for patients recommended to have 1-year follow-up and increased to 70% for those recommended to have 3-4 month follow-up. Gender and race/ethnicity had no significant impact in follow-up adherence rate. Severity of diabetic retinopathy and age were independent factors significantly associated with follow-up adherence (p <0.0001 and 0.0067 respectively).

 
Conclusions:
 

Adherence to follow-up and timeliness of follow-up were worse for those with mild diabetic retinopathy and for those patients less than 65 years of age. These findings could help target methods to improve follow-up adherence in high-risk groups.

 
Keywords: clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology • clinical (human) or epidemiologic studies: outcomes/complications • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×